Humoral and cell-mediated cross reactivity against EBOV GP1–649 and EBOV demonstrated that SUDV survivor sera from both cohorts, regardless of the time post infection, reacted against EBOV whole virus and EBOV GP1–649. The gene discussed is GTPBP1; the disease is infection.